Nada Ritambhra, Ramachandran Raja, Kumar Ashwani, Rathi Manish, Rawat Amit, Joshi Kusum, Kohli Harbir Singh, Gupta Krishan Lal
Department of Histopathology, Post Graduate Institute of Medical Education and Research, Chandigarh, India.
Department of Nephrology, Post Graduate Institute of Medical Education and Research, Chandigarh, India.
Int J Rheum Dis. 2016 Jul;19(7):721-9. doi: 10.1111/1756-185X.12675. Epub 2015 Sep 10.
Immunoglobulin-G4 (IgG4)-related tubulo-interstitial nephritis (IgG4TIN) could be the first presentation of IgG4-related systemic disease. Most of the data is from the West or Japan and retrospective, with good patient outcome.
This study was carried out from April 2011 to July 2013. We report a prospective follow-up of 11 patients who presented with renal dysfunction and had histological diagnosis of IgG4TIN followed for a minimum period of 1 year or until end-stage renal disease.
IgG4TIN constituted 0.28% of total renal biopsies and 6.5% of all tubulointerstitial nephritis. Patient ages ranged between 21 and 71 years with a male predominance. All the patients had renal dysfunction at presentation with a mean serum creatinine of 5.12 mg/dL. Proteinuria was subnephrotic except when there was coexisting membranous glomerulonephritis (36.4%). The mean 24-h urine protien excretion was 1.8 g. Serum IgG4 levels were elevated in 10 (90.9%) patients. Ten (90.9%) patients had renomegaly and one (9.1%) had focal renal mass. Extra-renal manifestations were present in seven (63.6%). Renal histology showed pattern A in five (45.5%), pattern B in four (36.3%) and pattern C in two (18.1%) patients. All but one patient (90.9%) received immunosuppressive therapy. Four (36.3%) achieved complete remission and three (27.2%) progressed to end stage renal disease. Two patients died due to infections while on steroid therapy. One patient with a mass had end stage renal disease for 12 months and did not improve with steroid therapy, and one (pattern C) had progressive chronic kidney disease on follow-up.
IgG4TIN in an Indian cohort most often presents with rapidly progressive renal failure and less often has extra-renal organ involvement. On follow-up, patients can experience a more aggressive course with progression to end stage renal disease.
免疫球蛋白G4(IgG4)相关性肾小管间质性肾炎(IgG4TIN)可能是IgG4相关性全身性疾病的首发表现。大多数数据来自西方或日本,且为回顾性研究,患者预后良好。
本研究于2011年4月至2013年7月开展。我们报告了11例出现肾功能不全且经组织学诊断为IgG4TIN患者的前瞻性随访情况,随访期至少1年或直至终末期肾病。
IgG4TIN占全部肾活检的0.28%,占所有肾小管间质性肾炎的6.5%。患者年龄在21至71岁之间,以男性为主。所有患者就诊时均有肾功能不全,平均血清肌酐为5.12mg/dL。除合并膜性肾小球肾炎时(36.4%)外,蛋白尿均为亚肾病范围。24小时尿蛋白平均排泄量为1.8g。10例(90.9%)患者血清IgG4水平升高。10例(90.9%)患者有肾肿大,1例(9.1%)有局灶性肾肿块。7例(63.6%)患者有肾外表现。肾组织学检查显示,5例(45.5%)为A模式,4例(36.3%)为B模式,2例(18.1%)为C模式。除1例患者外,其余所有患者(90.9%)均接受了免疫抑制治疗。4例(36.3%)实现完全缓解,3例(27.2%)进展至终末期肾病。2例患者在接受类固醇治疗期间因感染死亡。1例有肿块的患者患有终末期肾病12个月,类固醇治疗无效,1例(C模式)患者在随访中患有进行性慢性肾病。
印度队列中的IgG4TIN最常表现为快速进展性肾衰竭,较少有肾外器官受累。随访时,患者病情可能进展更为迅速,最终发展至终末期肾病。